APA (7th ed.) Citation

Hung, A. L., Maxwell, R., Belcaid, Z., Mathios, D., Luksik, A. S., Kim, E., . . . Park, S. (2018). TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM. OncoImmunology, 7(8), 1. https://doi.org/10.1080/2162402X.2018.1466769

Chicago Style (17th ed.) Citation

Hung, Alice L., et al. "TIGIT and PD-1 Dual Checkpoint Blockade Enhances Antitumor Immunity and Survival in GBM." OncoImmunology 7, no. 8 (2018): 1. https://doi.org/10.1080/2162402X.2018.1466769.

MLA (9th ed.) Citation

Hung, Alice L., et al. "TIGIT and PD-1 Dual Checkpoint Blockade Enhances Antitumor Immunity and Survival in GBM." OncoImmunology, vol. 7, no. 8, 2018, p. 1, https://doi.org/10.1080/2162402X.2018.1466769.